Your session is about to expire
← Back to Search
Other
Ultrasound Therapy for Healthy Subjects
N/A
Waitlist Available
Led By Robert M Fairchild, MD, PhD
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 24 hour post therapy
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing if ultrasound therapy can reduce inflammation in healthy adults. The study uses sound waves to create tiny vibrations in tissues, which might help lower inflammation. The results will help design a larger study for patients with Rheumatoid Arthritis. Ultrasound has been increasingly used for the clinical management of rheumatoid arthritis, particularly for assessing inflammation and monitoring therapy.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 24 hour post therapy
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 24 hour post therapy
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in inflammatory response measured by TNF-α
Secondary study objectives
Change in inflammatory response measured by Interleukin 1 (IL-1)
Interleukin-6
Change in inflammatory response measured by Tumor Necrosis Factor α (TNF-α)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Parameter testingExperimental Treatment1 Intervention
In order to test parameters, each individual will be subjected to four interventions with the ultrasound device, one sham intervention and 3 interventions with varying intensity, frequency, and duty cycle.
Group II: Anatomical targetingExperimental Treatment1 Intervention
In order to test anatomical targeting, each individual will be subjected to four interventions with the ultrasound device, one sham intervention and 2 interventions, varying the anatomical targets.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ultrasound device
2023
N/A
~50
Find a Location
Who is running the clinical trial?
Stanford UniversityLead Sponsor
2,484 Previous Clinical Trials
17,516,102 Total Patients Enrolled
Robert M Fairchild, MD, PhDPrincipal InvestigatorStanford University